Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/06/03 05:22:25」(JST)

wiki en

Antifibrinolytics, such as aminocaproic acid (ε-aminocaproic acid) and tranexamic acid are used as inhibitors of fibrinolysis.^[1] These lysine-like drugs interfere with the formation of the fibrinolytic enzyme plasmin from its precursor plasminogen by plasminogen activators (primarily t-PA and u-PA) which takes place mainly in lysine rich areas on the surface of fibrin. These drugs block the binding sites of the enzymes or plasminogen respectively and thus stop plasmin formation.

They are used in menorrhagia and bleeding tendency due to various causes. Their application may be beneficial in patients with hyperfibrinolysis because they arrest bleeding rapidly if the other components of the haemostatic system are not severely affected. This may help to avoid the use of blood products such as fresh frozen plasma (FFP) with its associated risks of infections or anaphylactic reactions.

In 2010, the CRASH-2 trial showed that the antifibrinolytic drug tranexamic acid safely reduces mortality in bleeding trauma patients.^[2]

The antifibrinolytic drug aprotinin was abandoned after identification of major side effects, especially on kidney.

The indication for use of antifibrinolytic drugs is made with various methods. The most rapid and suitable one is thromboelastometry (TEM) in whole blood, which is even possible in patients on heparin. With various assays, an enhanced fibrinolysis becomes visible in the curve signature (TEMogram) and from the calculated values, e.g. the maximum lysis parameter. A special test for the identification of increased fibrinolysis (APTEM) compares the TEM in the absence or presence of the fibrinolysis inhibitor aprotinin. In severe cases of activated fibrinolysis, this assay confirms the syndrome already in less than 15 min during the early phases of clot formation ^[3]

Bisobrin is a fibrinolytic agent.

References

^ "antifibrinolytic" at Dorland's Medical Dictionary
^ The CRASH-2 Collaborators (2010). "Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial". Lancet 376 (9734): 23–32. doi:10.1016/S0140-6736(10)60835-5. PMID 20554319.
^ Levrat A, Gros A, Rugeri L, Inaba K, Floccard B, Negrier C, David JS. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J of Anaesthesia 2008;100:792-7.

External links

Antifibrinolytics at the US National Library of Medicine Medical Subject Headings (MeSH)
MeSH list of agents 82000933

This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 冠動脈バイパス術後の合併症予防のための内科的治療 medical therapy to prevent complications after coronary artery bypass graft surgery
2. 成人における選択的脊椎手術のための麻酔 anesthesia for elective spine surgery in adults
3. 冠動脈バイパス術の心臓以外の早期合併症 early noncardiac complications of coronary artery bypass graft surgery
4. 止血の概要 overview of hemostasis
5. 血栓溶解異常による血栓性および出血性疾患 thrombotic and hemorrhagic disorders due to abnormal fibrinolysis

English Journal

Major perioperative complications after spine surgery in patients with cerebral palsy: assessment of risk factors.

Samdani AF1, Belin EJ, Bennett JT, Miyanji F, Pahys JM, Shah SA, Newton PO, Betz RR, Cahill PJ, Sponseller PD.
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society.Eur Spine J.2015 Jul 7. [Epub ahead of print]
PURPOSE: A prospective, longitudinal cohort was studied to determine the incidence, consequences, and risk factors of major perioperative complications in patients with cerebral palsy (CP) treated with spinal fusion. There is a wide variety of data available on the complications of spine surgery; ho
PMID 26148567
PMID 26151268

Eliminating the use of allogeneic blood products in adolescent idiopathic scoliosis surgery.

Berney MJ1, Dawson PH, Phillips M, Lui DF, Connolly P.
European journal of orthopaedic surgery & traumatology : orthopédie traumatologie.Eur J Orthop Surg Traumatol.2015 Jul;25 Suppl 1:219-23. doi: 10.1007/s00590-015-1624-3. Epub 2015 Mar 27.
PURPOSE: The aim of this study was to compare transfusion requirements in patients before and after the introduction of tranexamic acid as standard in patients undergoing spinal surgery for idiopathic scoliosis in a national orthopaedic hospital.METHODS: A retrospective chart review of 56 idiopathic
PMID 25813212